These findings build on a body of evidence suggesting relationships between carotenoid status to lipid metabolism and obesity, and are consistent with other epidemiological studies that demonstrate a prospective association between serum carotenoid levels and NAFLD [6,7,11], or between serum carotenoids and serum ALT [8,9]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.